Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06485284 · ClinicalTrials.gov registry record · NA
Evaluating the El Camino Program
A NA study, sponsored by Child Trends.
- Completed
- Registry status
- NA
- Development phase
- 746
- Enrollment target
NCT06485284: Completed NA study, sponsored by Child Trends.
NCT06485284 is a NA study that has completed, run by Child Trends. The registered enrollment target is 746 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06485284, a NA study, has completed, sponsored by Child Trends.
- COMPLETED
- Registry status
- NA
- Development phase
- 746 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial is to evaluate the impacts of El Camino, a goal-setting sexual health promotion program targeted toward Latino adolescents. The primary research questions are: * Research Question 1: Is participation in the El Camino goal setting program associated with greater abstinence (measured as never had sex, no recent sexual activity) relative to a comparison group that did not receive El Camino? * Research Question 2: Is participation in El Camino associated with reduced unprotected sex (measured as sex without any method of contraception, sex without a condom) for the intervention group relative to the comparison group? Researchers will compare those who received El Camino to a comparison group who received an alternative program that does not include sexual health components. As part of the study, participants will be asked to: * Attend approximately 11 hours of programming completed over 11 weeks * Complete baseline, post-intervention, and 12-month follow-up surveys * For select participants who received the El Camino program, participate in an optional focus group discussion
Primary Outcome
Ever had penis-in-vagina sex (yes/no). Dichotomous variable coded 1 if yes, 0 if no and missing otherwise
Interventions
- BEHAVIORAL El Camino
- BEHAVIORAL Life skills program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 746 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2024-01-25 |
| Phase | NA |
What the finished NCT06485284 record still lists
NCT06485284 is an interventional study that assigns participants to a tested intervention. The registered 746 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which El Camino is the first listed.
NCT06485284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06485284 about?
NCT06485284 is a clinical study titled "Evaluating the El Camino Program". The goal of this randomized controlled trial is to evaluate the impacts of El Camino, a goal-setting sexual health promotion program targeted toward Latino adolescents. The primary research questions are: * Research Question 1: Is participation in the El Camino goal setting program associated with ...
What is the current status of trial NCT06485284?
This trial is currently completed. It is a NA study. The enrollment target is 746 participants. The study started on 2021-02-17. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT06485284?
The interventions under investigation include: El Camino (BEHAVIORAL), Life skills program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06485284?
This trial is sponsored by Child Trends, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06485284's enrollment target sits among peer trials
746 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI